Travera
ApprovedTravera's Rapid Therapy Guidance™ evaluates a broad range of FDA-approved drug options to assess their potential for treating your unique cancer.
Founded
2018
Focus
Diagnostics
About
Travera's Rapid Therapy Guidance™ evaluates a broad range of FDA-approved drug options to assess their potential for treating your unique cancer.
Funding History
2Total raised: $13.5M
Series A$10MUndisclosedMar 15, 2022
Seed$3.5MUndisclosedJan 15, 2020
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile